TransMedics to Present at Upcoming September Investor Conferences
Rhea-AI Summary
TransMedics (Nasdaq: TMDX) announced participation in two New York investor conferences in September 2026. Management will join a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 3:20 p.m. EST and at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026, at 9:40 a.m. EST. A live and archived webcast of the fireside chat and the company’s standard investor presentation will be available in the Investors section of the TransMedics website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 04 | 2Q26 earnings report | Positive | -5.3% | Revenue increased 21% and guidance low end rose, but net income and operating margin declined. |
| Aug 03 | Inducement grants | Negative | -1.0% | New employee options and restricted stock units created additional equity compensation obligations. |
| Jul 28 | Conference presentation | Neutral | +2.2% | Management scheduled participation at the Canaccord Genuity Growth Conference. |
| Jul 21 | Earnings date notice | Neutral | -4.2% | The company scheduled release of second-quarter financial results for August 4. |
| Jul 06 | Strategic investment | Positive | +3.4% | TransMedics completed its strategic investment in PAD Aviation to support European logistics expansion. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent company news produced mixed reactions, including a negative response to the latest earnings report despite higher revenue guidance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Event: Morgan Stanley 24th Annual Global Healthcare Conference
Date: Monday, September 14, 2026
Time: 3:20 p.m. EST
Event: Baird 2026 Global Healthcare Conference
Date: Tuesday, September 15, 2026
Time: 9:40 a.m. EST
A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian Johnston
Hannah Jeffrey
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-september-investor-conferences-302865120.html
SOURCE TransMedics Group, Inc.